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 This work aimed the use of glucose/mannose lectins (Cramoll, 
EmaL and Con A) in the treatment of cutaneous wounds in 
mice.Surgical wounds were treated daily with the lectins and 
parameters such as edema, hyperemia, scab, granulation and 
scar tissues as well as contraction of wounds were analyzed. 
The lectin wounds showed higher edema and arrival of more 
polimorphonuclear cells at the site of lesions when compared 
with control group (0.15 M NaCl). Granulation tissue and 
collagen fiber deposition were observed with higher intensity in 
all lectin treated wounds promoting excellent closing and repair 
of lesions in less time than other groups. Results showed that 
Cramoll was more effective in the repair of experimental lesions 
in mice;however, the glucose/mannose lectins can be used as 
future cicatricial compounds. 
 
 
 
Introduction 
The healing process aims to recover anatomical 
and physiological integrity of tissue. The repair of 
a wound is a complex sequence of biochemical 
and cellular events in response to tissue lesion 
being divided in phases: hemostasis, 
inflammatory, proliferation or granulation and 
remodeling of the extracellular matrix (ECM) or 
maturation [1]. It is important to emphasize those 
significant variations in the nature, composition 
and duration of these phases in different wounds, 
depending on the location of tissue, degree of 
contamination and bacterial infection, sanguine 
irrigation and extension of injury to the tissue. The 
infection compromises reepithelialization and 
increases collagen deposition. Since prehistory, 
plants and their by-products were used to treat 
wounds and these biomaterials can be applied in 
the rehabilitation of injuries. Biomaterials are 
defined as any molecule that has the capacity to 
interact with the biological system without 
inducing an adverse response in the host. Among 
themare lectins, which constitute a heterogeneous 
group of proteins, structurally distinct, with two or 
more specific binding sites to mono or 
oligosaccharides. These molecules, purified 
mainly from different species of plants, have 
attracted great interest.Lectins have various 
biological activities, in particular, the interactions 
of plant lectins with human pathogenic bacteria 
and their immunomodulatory activity, 
lymphoproliferation, CD4-mediated signal 
transduction and functional activation of 
monocytes and macrophage-like cells [9]. Cramoll 
is a lectin extracted from seeds of Cratylia mollis 
Mart., a plant native to Northeastern Brazil. 
Cramoll is from the same Leguminosae family and 
Diocleinae subtribe as Concanavalin A (Con A; a 
lectin from Canavalia ensiformis seeds) and like 
Con A, Cramoll is glucose/mannose specific. 
Several studies have demonstrated the 
immunomodulatory profile of this lectin, 
production of IFN-γ and nitric oxide, mitogenic 
activity on human lymphocytes and antitumor 
activity. EmaL is a lectin obtained from Eugenia 
malaccensis L. seeds with antibacterial activity; it 
is also specific for glucose/mannose.Thus, in order 
to evaluate the effects of glucose/mannose lectins 
Cramoll, Con A and EmaL in topical applications, 
this study investigated in vivo clinical and 
histopathological aspects of cutaneous wounds 
experimentally performed in healthy and 
immunocompromised mice, to find an alternative 
biomaterial for repairing skin lesions. 
 
Methods 
C. mollis seed extract (10% w/v prepared in 
0.15M NaCl) was fractionated using ammonium 
sulphate (40–60% w/v) following by0.3 M D-
glucose bio-selectively elution with affinity 
chromatography in Sephadex G-75 [2]. EmaL was 
purified from a 10% (w/v) E. malaccensis seed 
extract in 0.15 M NaCl aqueous solution (crude 
extract, CE). CE was precipitated by 0–80% 
ammonium sulphate fractionation (F0-80) and the 
precipitate was further purified by 0.3 M glucose 
bio-specifically elution with affinity 
chromatography in Sephadex G-50 column. Con A 
from C. ensiformis (Jack bean) Type IV was 
purchased from Sigma Chemical Co., USA. 
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Females of albino Swiss mice (n = 30/group), 12 
weeks old (age 35–45 days, weight 25 ± 2 g), were 
used from the Bioterium of LIKA/UFPE. All mice 
were treated and killed in accordance with the 
Ethical Committee of UFRPE for Experiments 
with Laboratory Animals (Ministry of Health, 
Brazil, 012/02). Each animal was maintained in an 
individual cage, under controlled environmental 
conditions (12-h light/dark cycle, temperature 
23±2 ◦C and humidity55±10%) with water and 
commercial food ad libitum (Labina®, Agribrands 
of Brazil). Animals were divided into four groups 
treated daily with 100 µL (100 µg/mL) of Cramoll 
(Cramoll group – CraG), EmaL (Emal group – 
EG) and Con A (Con A group – ConG) solutions 
and 100 µL of NaCl 0.15 M (Control group – CG1 
and CG2), and were anesthetized for the surgical 
procedure. Each animal was placed in a prone 
position and prepared for aseptic surgery using 2% 
chlorhexidine digluconate. A standard wound was 
performed on the dorsal thoracic region. The 
clinical characteristics of the experimental wounds 
were 24 h after surgery, taking into consideration 
the following aspects: edema, hyperemia, 
secretion, bleeding, crust formation, scab, 
granulation, epithelialization and scar tissues.  On 
a daily basis, wound areas were measured using a 
pachometer and were calculated as follows: A = 
πR×r, where A, R and r are mean area, large ray 
and small ray, respectively. The calculation of the 
contraction degree was expressed in 
percentageusing the equations proposed by 
Ramsey [3], 100 x (W0 - Wi)/W0 = M ± SE (W0 
= initial area of the wound; Wi = area of the 
wound on the day of the biopsy; M = average; SE 
= stand error). At each time of biopsy, on the 2nd, 
7th and 12th days after surgery, animals were 
drawn from the experimental groups, subjected to 
subcutaneous anesthesia and euthanized by 
cervical disruption. Immediatelyafter the 
withdrawal of the skin, the samples were placed on 
a filter paper and settled in formaldehyde 4% (v/v) 
prepared in PBS 0.01 M pH 7.2 and submitted to 
the histopathology procedures. All results were 
expressed as mean values of groups±standard 
deviation and were analyzed considering the value 
of p < 0.05 asstatistically significant. 
 
Results 
Edema and hyperemia are characteristic signs of 
the pathophysiological point of view of 
inflammation and are directly related to local 
vasodilatation determined by vasoactive 
mediators, resulting in leakage of fluids into the 
extravascular space [17].Figure 1 shows the degree 
of hyperemia and edema of the wounds treated 
with CraG and ConG in relation to CG1. Edema 
was observed in the margins and/or the wound bed 
in all animals of groups, persisting after the second 
day except to CraG. The reduction of 
inflammatory signs were observed in CraG and 
ConG compared to CG1.  
 
 
 
 
 
Figure 1. Comparison of measured 
inflammatory signs (edema and hyperemia) within 
two days after the wound be promoted. 
 
The evolution of granulation tissue occurred 
exponentially especially in wounds treated by the 
CraG and ConG and more slowly in the CG1 
(Figure 2A). 
 
 
 
 
 
Figure 2. Frequency of granulation tissue (A) 
and scar tissue (B). 
 
The formation of exuberant granulation, which 
exceeds the height of the surrounding intact skin 
tissue was observed in 20% of the CG1; 5% of 
CraG and 20% in group ConG. In the fourth and 
fifth day, there was an initial formation of scar 
tissue in CraG and ConG. On the seventh day the 
wounds had its edges with formation of scar tissue 
which was observed in small numbers in wounds 
of CG1 (Figure 2B).At day 12, cutaneous flaws, 
got an average of 100% contraction in CraG and 
ConG and 92.12% in CG1 (Figure 3); noting that 
in this group, at the 12th day there was still 
granulation tissue and crusting. 
 
 
 
 
 
 
Figure 3. Average wound contraction during the 
period of 12 days.        NaCl,          Cramoll and  
     Con A. 
 
To EG it was observed during the inflammatory 
period the presence of edema, however, this 
clinical signal remained until the sixth day after 
surgery in the EG although in CG2 remained until 
the eighth day. On the sixth day no hyperemia was 
observed in EG, while 11.11% of the animals of 
the CG2 were still presenting this flogistic signal. 
In the first day it was observed the first crust only 
A B 
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in the group treated with EG (33.3%). Between the 
3rd to 5th and the 7th to 9th days 100% of EG 
presented the first crust, situation that did not 
occur in CG2. The second crust was identified 
macroscopically after the seventh day in EG and 
CG2 (Figure 4A and B). The presence of 
granulation tissue was observed between the fifth 
and seventh days in EG and CG2 (Figure 4C and 
D) and the peak in EG was obtained on the 
seventh day.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Variation with time of: clinical signals 
after the topic treatment with Emal (A) and 0.15 M 
NaCl (B); granulation and scar tissue after the 
topic treatment with EmaL (C) and NaCl 0.15 
M(D). 
 
The microscopic evaluation of the healing 
process was followed by the crust presence, 
infiltrated inflammatory cells, angiogenesis, 
granulation tissue and reepithelialization of lesion. 
On the seventh dayit was observed that there was a 
greater regression of granulation tissue, collagen 
deposition largest and most advanced re-
epithelialization in CraG compared to ConG and 
CG1 (Figura 5A, B and C).In the twelfth day, it 
was observed in CraG and ConG wound closure 
with complete re-epithelialization of the skin, 
which hyperplasia was associated with the 
regression of blood vessels in the dermis and 
better deposition and organization of collagen 
fibers, and formation of annex sprouts well 
developed in wounds of CraG. Partial re-
epithelialization of the wound with missing 
closing, was observed in CG1. In CraG and ConG 
during inflammatory and fibroplasia phase, it was 
observed the presence of different cell types such 
as neutrophils, eosinophils, lymphocytes, plasma 
cells and mast cells (Figure 5D, E and F).On the 
seventh day, the transition areas of the injuries of 
EG were characterized for presenting a more 
extensive reepithelialization towards the center of 
injurysupported by a fibrovascular granulation 
tissue compared to CG2 (Figure 6A and B). 
During the 12th day after surgery, 
reepithelialization was complete or partial in EG 
and CG2. With respect to the EG the transition 
areas were well organized, however, difficult to 
visualize due to the progression of the 
phenomenon. Moreover, the granulation tissue was 
fibrous (rich in collagen), presenting some small 
vessels (Figure 6C). With respect to CG2, only the 
presence of granulation tissue with fibrovascular 
and vascular characteristics was observed in the 
animals (Figure 6D).  
 
 
 
 
 
 
 
Figure 5. Histopathological views of the 
cutaneous wounds. Seventh day after surgery: 
NaCl (A), Cramoll (B) and Con A (C); 12th day 
after surgery: NaCl (D), Cramoll (E) and Con A 
(F).  
 
 
 
 
 
 
Figure 6. Histopathological views of the 
cutaneous wounds; 7th day after surgery: EmaL 
(A) and 0.15 M NaCl (B); 12th day after surgery: 
EmaL (C) and 0.15 M NaCl (D).  
 
Conclusion  
The results demonstrated that the lectins could 
be used in the process of cutaneous wounds repair. 
Future research on the applications of lectins 
obtained from medicinal plants, in biological 
systems, can be of great importance fortherapeutic 
treatments. 
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